Use of tumour markers in cancer diagnosis and treatment
Higgins, C.
Nursing Times 92(16): 36-37
1996
ISSN/ISBN: 0954-7762 PMID: 8710591 Document Number: 460934
This paper examines the laboratory identification of tumour markers--substances present in the blood and urine that are released by tumour cells or by the patient in response to a tumour. A general consideration of what constitutes a useful tumour marker is followed by a description of some specific tumour markers currently used in clinical practice. Reference is made to the potential impact of recent cancer research on initiatives for early cancer detection by testing blood.
Document emailed within 1 workday
Related Documents
Eskelinen, M.; Kataja, V.; Hämäläinen, E.; Kosma, V.M.; Penttilä, I.; Alhava, E. 1997: Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer Anticancer Research 17(2b): 1231-1234Tonkin, K.S.; Rustin, G.J.; Wignall, B.; Paradinas, F.; Bennett, M. 1989: Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased European Journal of Cancer and Clinical Oncology 25(12): 1739-1743
Sparholt, M.H.; Høgdall, E.; Høgdall, C.K. 2009: Tumour markers in epithelial ovarian cancer Ugeskrift for Laeger 171(48): 3505-3509
Gargano, G.; Correale, M.; Abbate, I.; Falco, G.; De Frenza, N.; Lorusso, V.; De Lena, M.; De Leonardis, A. 1990: The role of tumour markers in ovarian cancer Clinical and Experimental Obstetrics and Gynecology 17(1): 23-29
Fossa, S.D.; Paus, E. 1985: Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer Progress in Clinical and Biological Research 203: 121
Gaspar, M.J.; De Miguel, J.; García Díaz, J.D.; Díez, M. 2008: Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions Anticancer Research 28(5b): 2947-2952
Dei Poli, M.; Albertino, B.; Gasparri, G.; Casalegno, P.A.; Oliaro, A.; Rapellino, M.; Pecchio, F. 1990: Clinical importance of tumour markers in the diagnosis of squamous-cell carcinoma of the esophagus Panminerva Medica 32(3): 105-107
Avall Lundqvist, E.; Nordström, L.; Sjövall, K.; Eneroth, P. 1989: Evaluation of seven different tumour markers for the establishment of tumour marker panels in gynecologic malignancies European Journal of Gynaecological Oncology 10(6): 395-405
Kokhanenko, N.I.; Ignashov, A.M.; Varga, E.V.; Polkanova, M.S.; Aleshina, L.A.; Kimbarovskaia, A.A.; Osipenko, S.K.; Lebedev, E.G. 2001: Role of the tumor markers CA 19-9 and carcinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer Voprosy Onkologii 47(3): 294-297
Chantapet, P.; Riantawan, P.; Lebnak, P.; Getngern, P. 2000: Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer Journal of the Medical Association of Thailand 83(4): 383-391
van den Berg, G.A.; Nagel, G.T.; Muskiet, F.A.; Halie, M.R. 1985: Mass fragmentographic identification of polyamine metabolites in the urine of normal persons and cancer patients, and its relevance to the use of polyamines as tumour markers Journal of Chromatography 339(2): 223-231
Schwartz, M.K. 1976: Tumour markers, enzymes and hormonal markers Clinics in Gastroenterology 5(3): 653-663
Jelski, W.; Kedra, B.ła.; Szmitkowski, M. 2008: Alcohol dehydrogenase and aldehyde dehydrogenase as tumour markers and factors intensifying carcinogenesis in liver cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 25(146): 141-144
Kolberg, H.C.; Villena-Heinsen, C.; Deml, M.M.; Kraemer, S.; Diedrich, K.; Friedrich, M. 2005: Relationship between chemotherapy with paclitaxel, cisplatin, vinorelbine and titanocene dichloride and expression of proliferation markers and tumour suppressor gene p53 in human ovarian cancer xenografts in nude mice European Journal of Gynaecological Oncology 26(4): 398-402
Scholz, P. 1975: Blood group specific antigens in cancer and their significance for the histological tumour diagnosis Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 119(1-2): 22-26
Slavnov, V.N.; Markov, V.V.; Kovalenko, A.E.; Kovpan, N.A.; Kvacheniuk, A.N. 1997: Tumor markers in the diagnosis of thyroid cancer Likars'ka Sprava 4: 31-34
Torigoe, T.; Kato, H. 1983: Diagnosis and management of cancer using tumor markers Nihon Sanka Fujinka Gakkai Zasshi 35(9): 1672-1676
Kretschmer, H.; Hambsch, K.; Ludewig, R.; Grässer, A. 1974: Serological investigations with clostridial spores for tumour diagnosis. III. Experiments for tumour detection in early growth stages of jensen sarcoma in the rat Archiv für Geschwulstforschung 44(2): 100-102
Glybochko, P.V.; Popkov, V.M.; Kvetnoĭ, I.M.; Bliumberg, B.I. 2010: Neuroimmunoendocrinal markers in diagnosis and prognosis of a prostatic cancer surpine Urologiia 4: 72-75
Espinoza, A.R.; Lavi, J.; Otaño, N.; Arenilla, W.; León, R.; Espinoza, A.; Salvador, N.; León, A. 2019: Serum cellular inflammatory markers in the diagnosis of prostate cancer Archivos Espanoles de Urologia 72(7): 641-646